- Bank Stocks: Fear Trumps Fundamentals
- Week's Rally Still Leaves Some on the Sidelines
- Stock Chatter Focuses on Financials, Pharma
- Freddie Mac Takes Step Toward Issuing Stock
- Defrauded Fund Investors Sue Goldman
- Glum Consumers Focus on Cutting Debt, Savings
- Treasurys Move Lower as Earnings Sap Safety Bid
- Tech Stocks Spanked for Google, Microsoft's Shortfall
- Schlumberger Posts Better-Than-Expected Profit
- Web Extra: Your Earnings Edge And More
- Surprise Friday – Who Could It Be?
- The Latest Picks That Paid – Friday July 18th
- The Fast Money Misfires – Friday July 18th
- Pops & Drops: Intel, General Motors...
- The Future Of Wall Street
- Don’t Dump Everything Energy
- Can Apple Save Tech
- Kilduff: Iran Diplomacy = Lower Oil Prices?
Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded below $116 a barrel.
"People were chasing oil and gold for a while, but that got old," said Matt Cheslock, senior specialist at Cohen Specialists. "Big techs are the focus -- that's where the momentum is right now," he said. "They're selling commodities and buying banks and beaten-down techs."
"There hasn't been a new wave of cash into the market -- this is just redeploying cash that's out there," Cheslock said.
Among notable tech gainers, Google [GOOG
Loading...
()
] and Apple [AAPL
Loading...
()
] gained more than 1 percent, while BlackBerry maker Research In Motion [RIMM
Loading...
()
] jumped more than 3 percent.
IBM [IBM
Loading...
()
] rose 1 percent after the company announced it was raising its dividend by 25 percent to 50 cents a share. This is 13th straight year that IBM, the world's largest computer-services company, has increased its payout to shareholders. Just two weeks earlier, IBM reported better-than-expected earnings and raised its 2008 outlook.
Yahoo [YHOO
Loading...
()
] rose 3 percent amid "signs of willingness among traders to position for a conciliatory break higher in Yahoo shares," said Rebecca Engmann Darst, an equity-options analyst at Interactive Brokers. A break in the "silent standoff" is expected any day now since Microsoft's [MSFT
Loading...
()
] deadline came and went this weekend without a peep from Yahoo. Microsoft shares fell 1 percent.
Still, jitters ahead of the Federal Reserve's decision on interest rates kept a lid on trading. All three major indexes -- the Dow Jones Industrial Average, S&P 500 and Nasdaq -- remained within half a percentage point of their previous close.
The Fed kicked off its two-day meeting Tuesday. The market is pricing in about an 80-percent chance of a quarter-point rate cut to 2 percent when the Fed issues its decision on Wednesday, according to fed-funds futures contracts.
From 'Mad Money': |
The two most likely outcomes the market expects are: 1) a final quarter-point cut and an indication in the statement that this cycle of cuts is over, and 2) that the Fed will hold steady.
Still, some Fed watchers say Wall Street may be too optimistic that the Fed is done cutting rates.
Crude oil [US@CL.1
Loading...
()
] dropped more than $3 to settle at $115.63 a barrel, after pushing $120 in the previous session, as worries about supply disruptions subsided.
"Oil is getting quite frothy," Cheslock said, referring to the fact that there is now $30 or $40 in excess speculation on the price, far above the typical $5 to $10 to cover geopolitical risk. "When traders see oil down $3.50 heading into a Fed meeting, that's a good sign."
Oil's fall put wind beneath the wings of airline stocks, which rose more than 2 percent. Delta [DAL
Loading...
()
] rose more than 10 percent and Northwest [NWA
Loading...
()
]was up nearly 20 percent.
Despite oil's slide, Chevron [CVX
Loading...
()
] jumped 2.4 percent, making it the best performer on the Dow, after Goldman Sachs upgraded its rating on the integrated oil sector to "attractive" from "neutral," saying risk/reward was most favorable for the "super majors" such as Chevron and ConocoPhillips [COP
Loading...
()
].
From 'Fast Money': |
Merck shares [MRK
Loading...
()
] plunged more than 10 percent, making it the biggest decliner on the Dow, as several analysts lowered their price targets and earnings estimates for the drug maker after the FDA unexpectedly rejected Merck's Cordaptive, saying it needs more information on the drug. Cordaptive is seen as a key to Merck's cholesterol franchise.
Shares of Genentech [DNA
Loading...
()
] and Biogen [BIIB
Loading...
()
] skidded 7.1 percent and 5.2 percent, respectively, after the biotech companies said studies showed their drug Rituxan didn't meet its primary goal of helping patients with lupus, a disease affecting the immune system that can be fatal.
Bank and homebuilder shares declined after a pair of dismal reports. The Dow Jones home-construction index fell 0.8 percent, while the S&P financial index was down 0.6 percent.
U.S. home prices extended their slump in February, with 17 of the 20 measured regions posting record annual declines, according to a report from Standard & Poor's/Case Shiller. A separate report showed home foreclosure filings jumped 23 percent in the first quarter from the prior quarter and more than doubled from a year earlier, according to real-estate tracker RealtyTrac.
In other economic news, the Conference Board's consumer-confidence gauge dropped to 62.3, a five-year low, in March from 65.9 in April. However, that was slightly better than the 61-62 range economists had expected.
On the earnings front, U.S. credit-card companies posted strong results as consumers increasingly pay with plastic instead of cash and checks.
Mas




